Genentech Provides Update on Phase III Ocrevus High Dose Study in People With Relapsing Multiple Sclerosis

4 months ago 12
Read Entire Article
  1. Homepage
  2. Finance
  3. Genentech Provides Update on Phase III Ocrevus High Dose Study in People With Relapsing Multiple Sclerosis

Related

Form 144 BANC OF CALIFORNIA For: 29 August

Form 144 BANC OF CALIFORNIA For: 29 August

1 minute ago 1
US will proceed with probe of solar imports from India, Laos and Indonesia

US will proceed with probe of solar imports from India, Laos...

1 minute ago 1
Form 13G Defiance ETFs For: 29 August

Form 13G Defiance ETFs For: 29 August

1 minute ago 0

Trending

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

7 months ago 492
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

7 months ago 238
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

5 months ago 197
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

5 months ago 196
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

6 months ago 187
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved